Clinical Trial Update: PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 pilot study investigating PET imaging of cancer patients with the radiopharmaceutical 124I-PUH71, with the trial status currently ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• 124I-PUH71 (Iodine-124 labeled PUH71)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-Hodgkin's Lymphoma, Myeloma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING